Central Lab Market Size & Share, by Service Type (Genetic Services, Microbiology Services, Biomarker Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services); End-user (Biotechnology Companies, Pharmaceutical Companies, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4233
Published Date: Feb 14, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Central Lab Landscape

Laboratory Corporation of America Holdings (Labcorp)
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
ICON Plc
Medpace, Inc.
Eurofins Scientific (Ireland) Limited
LabConnect
Cerba Research NV
Frontage Laboratories, Inc.
Lambda Therapeutic Research Limited
InVitro International (IVRO)
Clinical Reference Laboratory,inc

Browse Key Market Insights with Data Illustration:

Central Lab Market Size & Share, Global Forecast Report 2035

In the News

Laboratory Corporation of America Holdings (Labcorp), declared the launch of the first broadlyavailable test, Neurofilament Light Chain (NfL), that delivers direct indicationof neurodegeneration and neuronal injury.
Eurofins Scientific (Ireland) Limited, announced the launch of RT-PCR kits thatoffersthe toolset for rapid detection of fast spreading SARS-CoV-2 variant B.1.1.529.

Frequently Asked Questions (FAQ)

Growing prevalence of genetic disorders, rise in genetic testing, increasing prevalence of cancer, and growing investment in R & D are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Requirement of high capital investments to operate central lab, problems associated with contamination of samples, and stringent government regulationsare estimated to hamper the market growth

The market in North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market areLaboratory Corporation of America Holdings, ICON Plc, Medpace, Inc.,Eurofins Scientific (Ireland) Limited, LabConnect, Cerba Research NV, Frontage Laboratories, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by service type, end-user, and by region.

The pharmaceutical companies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Central Lab Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the central lab market?

What would be the CAGR of central lab market over the forecast period?

What are the challenges affecting the central lab market growth?

Which region will provide more business opportunities for growth of central lab market in future?

Who are the major players dominating the central lab market?

How are the company profiles selected?

What are the segments in the central lab market?

Which segment captures the largest market size in end-user segment in the central lab market?